As reported in previous papers1'2*, we have described the isolation and characterization of benarthin (1), as well as the taxonomy and fermentation of Streptomyces xanthophaeus. The structure was determined to be L- (2,3-dihydroxybenzoyl) arginyl-L-threonine ( Fig. 1) . In this paper, we report the synthesis of 1 and the structure-activity relationships ofbenarthin derivatives against pyroglutamyl peptidase (PG-peptidase). (1) and its derivatives (18, 19 and 20) .
Synthesis of Benarthin
The total synthesis of 1 is shown in Scheme 1. L-(A^a-Boc-A^<o-di-Zt)arginyl-L-threonine benzyl ester (4) was synthesized by condensation of L-(Ara-Boc-Arco-di-Z)arginine (2) and L-threonine benzyl ester (3) in dry DMFusing dicyclohexylcarbodiimide (DCC) and . Selective removal of the a-amino protective group of compound4 was accomplished by treatment with CF3COOH togive5.
2,3-Dibenzyloxybenzoic acjd (8) was prepared from 2,3-dihydroxybenzoic acid (6) by reaction with benzylbromide in dry acetone in the presence of K2CO3followed by hydrolysis of the resulting benzyl ester (7) with sodium hydroxide.
L-(A^£0-Di-Z)arginyl-L-threonine benzyl ester (5) was condensed with 2,3-dibenzyloxybenzoic acid (8) in dry DMFusing DCC and HOBt to form L-(Na-2,3-dibenzyloxybenzoyl-A^-di-Z)arginyl-L-threonine benzyl ester (9) . Finally, hydrogenolysis of 9 using palladium-black gave L- (2,3-dihydroxybenzoyl) arginyl-Lthreonine (benarthin). The physico-chemical2) and spectral properties of synthetic benarthin were the same as those of the natural product.
Structure-activity
Relationships of Benarthin and Its Derivatives for
Benarthin derivatives (10~17) were prepared using the method employed in the synthesis of 1. Benarthin methyl ester (18) was obtained by treatment with HCl-MeOH.Dimethyl benarthin (19, L-(2,3-dimethyloxybenzoyl) arginyl-L-threonine) was obtained by treatment with trimethylsylyldiazomethane in dry MeOH. Dimethylpyrimidinyl benarthin (20) was prepared by treatment with 2,4-pentanedione.
Scheme 1. Synthesis of benarthin.
f Z=Benzyloxycarbonyl. peptidase by the compounds synthesized was tested in order to determine structure-activity relationships. The activity was measured as reported previously1} in order to determine the concentration of the inhibitor required for 50% inhibition (IC50). The IC50 values of these derivatives are shown in Tables 1, 2 and 3.
The effect of hydroxyl groups on the benzoyl moiety was investigated as shown in Table 1 . The compound (13) with the 3,4-dihydroxybenzoyl group showed almost the same activity as the compound (1) with the 2,3-ctihydroxybenzoyl group. However, the compound (12) with the 2,5-dihydroxybenzoyl group showed lower activity than compound 1. Other compounds exhibited much lower activity. These results indicated that vicinal hydroxyl groups on the benzoyl group are essential for activity. The effects of the arginine and threonine moieties were investigated as shown in Table 2 . It was apparent that the guanidino group of arginine and the free carboxylic acid group of threonine had relatively little effect on activity. The peptide moiety of 1 appeared to be of little importance in the inhibition of PG-peptidase. Furthermore, as shown in Table 3 , catechol itself and 2,3-dihydroxybenozic acid showed much more inhibitory activity than 1, however 2-hydroxybenzoic acid and benzoic acid showed no such activity. The results indicated that the vicinal hydroxyl function on the benzene ring was important for inhibition of PG-peptidase. VOL.45 NO.7 THE JOURNAL OF ANTIBIOTICS 1091 A variety of catechol siderophore compounds such as azotochelin3), aminochelin4) and myxochelin A5) have been described from bacterial sources. These compounds are produced as iron chelators under iron deprived conditions, however, the biosynthesis of benarthin was not necessarily a result of iron deficiency and iron had no effect on the inhibitory activity of benarthin against PG-peptidase. Vanoxonin6'7) which is structurally related to 1 was found to be an inhibitor ofthymidylate synthetase.
Vanoxonin is also a catechol siderophore compound. The vicinal hydroxyl groups, like those of 1, are essential for the inhibitory activity of vanoxonin against thymidylate synthetase. But, unlike 1, the peptide moieties of vanoxonin are also important for inhibitory activity against thymidylate synthetase. In addition, vanadium was found to be a specific activator of vanoxonin, but the metal had no effect on the inhibitory activity of 1 against PG-peptidase. It would be interesting to resolve the mechanisms of PG-peptidase8) and thymidylate synthetase9) inhibition by benarthin and vanoxoin, respectively.
Experimental
General NMR spectra were recorded on a Joel JNM-GX400 NMR spectrometer and mass spectra were measured using a Joel JMS-SX102 spectrometer. UV spectra were recorded on a Hitachi U-3210 spectrometer and IR spectra on a Hitachi 1-5020 FT-IR spectrometer. Optical rotations were measured on a Perkin-Elmer 241 polarimeter and melting points on a Yanaco SP-S3 and MP-500D.
Benzyl Ester (4) HOBt (205mg) and DCC (208mg) were added to an ice bath-cooled solution of L-(7Va-Boc-A^-di-Z)arginine (2, 505mg) and L-threonine benzyl ester (3, 220mg) in dry DMF (2ml) while stirring.
After stirring for 5 hours at room temperature, the undissolved material was removed by filtration and the filtrate was evaporated and dissolved in EtOAc (30ml). This material was washed with 5% aq NaHCO3, 1%aq citric acid and saturated aqNaCl, dried with Na2SO4, filtered and evaporated. The residue was dissolved in CHC13and was applied to silica gel column (2.5 x 30cm) and eluted with CHCl3 -MeOH (100: 1). The main fractions were evaporated to give a colorless powder (4, 408mg, 61%) FAB-MS m/z 734 (M+H)+, 600 (M-COOBzl)+; Anal Calcd for C38H47N5O10: N 9.54, found: 9.61.
2,3-Dibenzyloxybezoic Acid (8) Benzylbromide (1.2ml) was added dropwise to a solution of 2,3-dihydroxybenzoic acid (6, 505 mg) and K2CO3 (1,850mg) in dry acetone (12ml). The reaction mixture was refluxed for 14 hours at 65°C. The undissolved material was removed by filtration and the filtrate was evaporated. The residue was dissolved in dioxane (5ml) and 2n NaOH(4ml) was added. After refluxing for 40 minutes at 110°C, 2n HC1 (4ml) was added and the reaction mixture was evaporated. CHC13(50ml) was added to the residue which was washed with H2O, dried with Na2SO4, filtered and evaporated. Crystallization from EtOAc gave colorless prisms (8, 813mg, 76%) L-(A^(X-2,3-Dibenzoyloxybenzoyl-A^co-di-Z)arginyl-L-threonine Benzyl Ester (9) Trifluoroacetic acid (2ml) was added to an ice bath-cooled solution of compound 4 (169mg) in dry dichloromethane (0.5 ml) while stirring. Stirring was continued for 50 minutes at room temperature and the dichloromethane was evaporated. The residue was extracted with EtOAc(10ml), washed with 5% aqNaHCO3and saturated aqNaCl, dried with Na2SO4and concentrated to give a ninhydrin positive compound 5 (172mg). HOBt (47mg) and DCC(55 mg) were added to an ice bath-cooled solution prepared from compound 5 (148mg) and compound 8 (81mg) in dry DMF(3ml). After stirring for 19 hours at room temperature, the resulting precipitate was removed by filtration. EtOAc (30ml) was added to the filtrate, and the mixture was washed with 5%aq NaHCO3, 1%aq citric acid and saturated aqNaCl. This JULY 1992 material was dried with Na2SO4 and evaporated to give a colorless powder (222mg). The residue was dissolved in CHC13, applied to a silica gel column (2.5 x 10cm) and was eluted with CHC13. Concentration of the main fractions gave a colorless oily residue (9, 147mg, 67%) Palladium black (7.8 mg) was added to a solution prepared from L-(A^a-benzoyl-7VC0-di-Z)arginyl-Lthreonine benzyl ester (90mg), CHC13 (l ml), and MeOH(1.5ml). The atmosphere was replaced with hydrogen at atmospheric pressure and stirring was continued for 24 hours at room temperature. The catalyst was removed by filtration and the filtrate was concentrated to dryness. Purification was performed by CPC, employing the following conditions: BuOH -AcOH-H2O (upper phase stationary, 750 : 50 : 750), 4ml/minute, 900 rpm, 20°C, detection 254 nm. The main fractions were collected, concentrated to a small volume and were lyophilized to give a colorless powder of L-(benzoyl)arginyl-L-threonine acetate (10 
benzyl ester (54 mg) was treated using the same procedure as employed with L-(A/^a-2,3-dibenzoyloxybenzyl-A^ft)-di-Z)arginyl-L-threonine benzyl ester in the synthesis of 1 yielding a colorless powder of L- (2,4-dihydroxybenzyl) 
benzyl ester (58 mg) was treated using the same procedure as employed with L-(Na-2,3-dibenzoyloxybenzyl-iVw-di-Z)arginyl-L-threonine benzyl ester in the synthesis of 1 yielding a colorless powder of L- (2,5-dihydrobenzyl) 
benzyl ester (53 mg) was treated using the same procedure as employed with L-(A^a-2,3-dibenzoyloxybenyl-A^f0-di-Z)arginyl-L-threonine benzyl ester in the synthesis of 1 yielding a colorless powder of L- (3,4-dihydroxybenzyl) 
benzyl ester (30 mg) was treated using the same procedure as employed with L-(Na-2,3-dibenzoyloxybenzyl-A^-di-Z)arginyl-L-threonine benzyl ester in the synthesis of 1 yielding a colorless powder of L- (3,5-dihydroxybenzyl) .
L-(A^a-2-Benzoyloxybenzyl-A^w-di-Z)arginyl-L-threonine benzyl ester (37 mg) was treated using the same procedure as employed with L-(A/^a-2,3-dibenzoyloxybenyl-A^a-di-Z)arginyl-L-threonine benzyl ester in the synthesis of 1 yielding a colorless powder of L-(2-hydroxybenzyl)arginyl-L-threonine acetate (15) (38 mg, 87% L- (2, threonine (16) L- (2, threonine benzyl ester (84mg) was treated using the same procedure as employed with L-(A^a-2,3-dibenzoyloxybenzyl-A^ctJ-di-Z)arginyl-L-threonine benzyl ester in the synthesis of l-(2,3-dibenzoyloxybenzyl-A^-di-Z)arginyl-L-threonine yielding a colorless powder of L- (2,3- L- (2, arginine (17) L-(iVa-2,3-Dibenzoyloxybenyl-A^C0-di-Z)arginine benzyl ester (100 mg) was treated using the same procedure as employed with L-(Afa-2,3-dibenzoyloxybenyl-A^-di-Z)arginyl-L-threonine benzyl ester in the synthesis of 1 yielding a colorless powder of L- (2,3-dihydroxybenzyl) arginine acetate (17) (35 mg, 97%).
